IRVINE, Calif.–(BUSINESS WIRE)–The German company joimax®, developer of technologies and training methods for minimally invasive endoscopic spinal surgery, today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endoscopic Lumbar Interbody Fusion, or

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone